California live-discharge audits: what a Qlarant letter means and who's exposed

The enforcement logic is statistical: unusually high live-discharge rates — patients electing hospice and then leaving alive at rates far above norms — are among the strongest claims-visible indicators of admission-eligibility problems, and California's distribution of that metric is what drew the concentrated federal attention, alongside criminal enforcement actions against Southern California hospice fraud rings this spring. Industry analyses of the audit wave indicate the trigger band centers on live-discharge rates above roughly 40% in the cited window, with exposure concentrated in Los Angeles County.

Two things can be true at once: the enforcement targets real fraud, and legitimate hospices with defensible clinical reasons for elevated live discharges (long-stay dementia populations, high revocation-for-treatment rates) can land inside the statistical band. For the legitimate operator, the difference between an uncomfortable audit and a payment suspension is documentation quality on eligibility determinations — certification narratives, decline evidence, and discharge rationale that hold up on paper without the clinician in the room to explain.